OncoImmunology · 2015 · 43 citations · 37 references
MedicineCancer BiologyOncologyCancer ImmunologyCell TherapyImmunotherapyCancer Stem Cell BiologyCancer Stem CellsCytokine-based TherapyNatural Killer Cell BiologyNatural Killer Cell RegulationNatural Killer Cell TherapyCancer Stem Cell TargetingCancer Stem-like CellsCytokine Production By Natural Killer CellsCytokine-induced Natural Killer Cell TherapyCytokine-mediated Cell DeathNatural Killer Cell Receptor Nkg2dNkg2d-mediated RecognitionTime-lapse Imaging
against putative CSCs of HCC, as shown by tumorsphere formation and time-lapse imaging. Additionally, time-lapse recording firstly revealed that putative CSCs were attacked simultaneously by many CIK cells and finally eradicated by CIK cells, indicating the necessity of achieving sufficient effector-to-target ratios. We firstly illustrated that anti-NKG2D antibody blocking partially but significantly inhibited CKA of CIK cells against putative CSCs. More importantly, intravenous infusion of CIK cells remarkably delayed tumor growth in mice with a significant decrease in putative CSC number monitored by bioluminescence imaging. Taken together, these findings demonstrate CKA of CIK cells against putative CSCs of HCC, at least in part, by NKG2D-ligands recognition.
37
Juan Lü, Ming‐Liang He, Lu Wang et al. · Cancer Research · 2011 · 385 citations · Full text
Medicine, Cancer Biology, Oncology +17
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
Michael R. Verneris, Mobin Karami, Jeanette Baker et al. · Blood · 2003 · 379 citations